Lataa...
Immunotherapy of COVID-19 with poly (ADP-ribose) polymerase inhibitors: starting with nicotinamide
COVID-19 induces a proinflammatory environment that is stronger in patients requiring intensive care. The cytokine components of this environment may determine efficacy or otherwise of glucocorticoid therapy. The immunity modulators, the aryl hydrocarbon receptor (AhR) and the nuclear NAD(+)-consumi...
Tallennettuna:
| Julkaisussa: | Biosci Rep |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Portland Press Ltd.
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7601349/ https://ncbi.nlm.nih.gov/pubmed/33063092 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BSR20202856 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|